Explore the 2023 RC Capital Senior Management Compensation Survey, which summaries results from 35 private-growth companies in healthcare and IT ..read more

The landscape of medical device investing is as competitive as ever before – putting pressure on companies to present stellar, “better, faster, cheaper” solutions. Here are eight qualities that investors are looking for in potential portfolio companies to ensure that you’re putting your best foot forward when presenting to these ever-vigilant investment teams ..read more

Thirty-one private-growth companies from the healthcare and IT sectors participated in this year’s survey. Companies provided data on compensation components – cash and stock – for senior management and independent directors, as well as data with respect to D&O insurance and audit expenses ..read more

To provide medical device and technology companies with a greater perspective on successfully navigating VACs, we spoke with four River Cities’ med tech portfolio companies that have dedicated countless hours to mastering the pathway to get innovative products in front of and approved by these ever-vigilant committees ..read more

To alleviate a bit of the unknown as it relates to the world of Medtech, we went straight to the sources and surveyed our database of Medtech companies to see how they have been impacted by COVID ..read more

We spoke with Adelaide Whitehead, Employee Experience and Talent Acquisition Manager for Liquibase, about how the company is approaching its Diversity, Equity and Inclusion (DE&I) strategy ..read more

We spoke with Nic Aldrich, Vice President of Marketing for OrthAlign, about how the company is approaching its medtech social media strategy ..read more

Thirty-five private-growth companies from the Healthcare and IT sectors participated in this year’s survey. Companies provided data on compensation components – cash and stock – for senior management and independent directors, as well as data with respect to D&O insurance and audit expenses ..read more